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Abstract
Rickettsia felis is a spotted fever group rickettsia that has been deﬁnitely described in 2002. Within the last 20 years, there have been a
growing number of reports implicating R. felis as a human pathogen, parallel to the fast-growing reports of the worldwide detection of
R. felis in arthropod hosts, mainly the cat ﬂea Ctenocephalides felis felis. R. felis is now known as the agent of the so-called ﬂea-borne
spotted fever, with more than 70 cases documented in the literature. Recently, two studies respectively conducted in Senegal and
Kenya, have challenged the importance of R. felis infection in patients with unexplained fever in sub-Saharan Africa. We focus here on
the epidemiological and clinical aspects of R. felis infection. More studies are needed, including the study of other arthropod vectors,
but it can be speculated that R. felis infection might be an important neglected agent of fever in sub-Saharan Africa.
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Rickettsia felis is an obligate intracellular Gram-negative bacte-
rium belonging to the spotted fever group (SFG) of Rickettsia
[1,2]. It was probably ﬁrst detected in European cat ﬂeas
(Ctenocephalides felis felis) in 1918 and tentatively named ‘Rick-
ettsia ctenocephali’ [3]. This work was, however, overlooked
until 1990, when a Rickettsia-like organism (the ‘ELB agent’,
for the Elward Laboratory, Soquel, CA, USA) was found in
C. felis ﬂeas by electron microscopy [4]. The species R. felis
was formally validated by molecular criteria in 2001, and the
reference strain was isolated and deﬁnitely characterized in
2002 [5]. Particularly, it was shown that that this rickettsia
can be cultivated at low temperature only. Recent outcomes
include the study of the genome of R. felis [6]. The presence
of up to two plasmid forms has been shown, as well as strain
variation of plasmid content [7,8].
A Worldwide-distributed Rickettsia
Since its deﬁnitive description, the interest in R. felis and its
association with ﬂeas has increased [1,9]. The use of molecu-
lar assays, including regular and quantitative real-time poly-
merase chain reaction (qPCR) has provided rapid and
reproducible tools to detect R. felis in arthropods. R. felis has
now been described in infected arthropods from more than
20 countries on ﬁve continents (Fig. 1). In America, after the
USA, Brazil and Mexico, it has been found in ﬂeas from Peru,
Uruguay, Chile, Argentina [1,9] and recently Hawaii [10],
Canada [11], Panama [12], and the Caribbean Island St Kitts
[13]. In Europe, R. felis has been detected in ﬂeas from Spain,
France, the UK, Portugal, Cyprus [1,9] and recently Germany
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[14] and Italy [15]. In Asia, it has been detected in Japan,
Indonesia, Thailand, Afghanistan, Israel [1,9] and recently
Laos [16], Taiwan [17] and Lebanon [18]. It has also been
detected in Australia, New Zealand [1,9] and New Caledonia
[19]. Finally, in Africa, R. felis has been detected in ﬂeas from
Algeria, Ethiopia, Gabon [1,9], and recently the Ivory Coast
[20] and Morocco (Parola P, unpublished data).
Beside C. felis, new arthropods have been found to be
infected with R. felis, including: other ﬂea species (C. canis,
C. orientis, Anomiopsyllus nudata, Archaeopsylla erinacei, Ctenoph-
thalmus sp., Xenopsylla cheopis X. brasilliensis, Tunga penetrans,
Ceratophyllus gallinae, Spilospsyllus cuniculi and Echidnophaga
gallinacean); ticks (Haemaphysalis ﬂava, Rhipicephalus sanguin-
eus, Ixodes ovatus, and Carios capensis); and chigger (South
Korea) and mesostigmata mites (Taiwan) [1,9,20]. The
reported hosts for these vectors were mainly cats, dogs and
rodents, and more rarely opossums, hedgehogs, horses,
sheep, goats, gerbils and monkeys [1,9].
However, most of the reports state that the cat ﬂea C. felis
is the most recurrent arthropod in which R. felis has been
detected. Furthermore, C. felis is currently the only known
biological vector of R. felis [9]. Within the ﬂea, R. felis infection
is disseminated, having been identiﬁed in the midgut, ovaries
and salivary glands [21]. Studies examining the transmission of
R. felis using colonized cat ﬂeas have shown stable vertical
transmission (transovarial and trans-stadial) [9,22]. Vertical
transmission of R. felis persists in C. felis for at least 12 genera-
tions without the aid of an R. felis-infected bloodmeal; how-
ever, over successive generations prevalence wanes to low
levels (10%) [22]. It has also been recently shown that cat ﬂeas
are able to acquire R. felis infection from an infectious blood
meal [23]. These data further support the wide distribution of
R. felis in relation to the worldwide distribution of C. felis. The
cat ﬂea is extremely common on cats and dogs in many
temperate and tropical regions, but it also infests opossums,
raccoons and rats [24]. It represents the great majority of ﬂeas
in human homes. If associated with an infectious agent, the
worldwide distribution of C. felis represents therefore a threat
to the human population because of lack of host speciﬁcity of
the cat ﬂea, and its ability to bite people.
The Emerging Flea-borne Spotted Fever
In 1994, ‘ELB agent’ DNA fragments were detected in blood
samples obtained from a patient from Texas in 1991 [25]. This
became the ﬁrst evidence of R. felis’ potential as a human path-
ogen. More arguments for the pathogenicity of R. felis for
humans were provided in 2000 in Mexico, when three patients
with fever, exanthem, headache and central-nervous system
involvement were diagnosed with R. felis infection by speciﬁc
PCR of blood or skin and seroconversion to rickettsial anti-
gens [26]. All the patients had had contact with ﬂeas or animals
known to carry ﬂeas. In 2001, high antibody titres to R. felis
were found in two French patients with clinical signs of rickett-
sioses and two of 16 Brazilian patients with febrile rash. More-
over, speciﬁc sequences of R. felis were identiﬁed in the serum
of one Brazilian patient [27]. In 2002, two cases of typical spot-
ted fever were reported in an adult couple in Germany. Clini-
cal features included fever, marked fatigue, headache,
generalized maculopapular rash and a single black, crusted,
cutaneous lesion surrounded by a halo, and enlarged, painful
lymph nodes in the inguinal region for the man. Serological
techniques discriminated R. felis infection among several rick-
ettsiae for the woman and this was conﬁrmed by detection of
R. felis DNA in the woman’s sera [28]. Thereafter, within
the last 20 years, there have been a growing number of
reports implicating R. felis as a human pathogen, parallel to the
FIG. 1. Distribution by 2011 of clinical ﬁndings of Rickettsia felis infections (yellow stars) and of arthropods infected with R. felis (red circles).
The numbers in the stars indicate the number of clinical cases. In these countries (but not yet Tunisia, Senegal and Kenya) R. felis has also been
detected in arthropods. The red circles indicate locations where R. felis has been detected in arthropods (mainly ﬂeas) only. Updated from [29].
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fast-growing reports of the worldwide detection of R. felis in
arthropod hosts [1]. In 2009, together with the report of a
French case, a PubMed search found reports (case reports and
seroprevalence studies) of 68 R. felis infections [29]. Cases of
the so-called ﬂea-borne spotted fever (also referred to as cat
ﬂea typhus) had been reported in the Americas (Brazil and
Mexico), Asia (Thailand, South Korea and Laos), Northern
Africa (Tunisia and Egypt) and Europe (France, Germany and
Spain) [29]. The available clinical ﬁndings for 34 persons
infected with R. felis included fever (32 cases), cutaneous rash
(24 cases, mostly maculopapular), cutaneous eschar (four
cases), neurological signs (ﬁve cases), digestive symptoms,
cough without pneumonia (three cases), and pneumonia (two
cases) [29,30]. However, clinical ﬁndings for R. felis are often
confused with those found for patients with murine typhus
caused by R. typhi, or other febrile illnesses, and they appear
to be more complex and more severe than initially thought.
Since 2008, a case has been diagnosed with acute polyneuropa-
thy-like symptoms [30]. Recently, two cases of subacute men-
ingitis caused by R. felis have been documented in Sweden
[31]. More interestingly, a case of what has been documented
by serology as murine typhus was reported in 2008 in Israel
[32]. At the end of 2010, the authors revised the diagnosis,
which was retrospectively documented by molecular tools as a
R. felis infection, the ﬁrst in the Middle-East region [33].
Like other rickettsiose, R. felis infections can be diagnosed
by serological testing, microimmunoﬂuorescence (MIF) being
the method of reference [34]. However, most commercially
available MIF assays offer a very limited selection of antigens
(e.g. R. rickettsii in the United States or R. conorii and R. rick-
ettsii in France for the spotted fever group; R. typhi for the
typhus group). Even national reference centres may routinely
test for only a few other SFG rickettsiae (e.g. R. akari or
R. africae). Serological proﬁles for R. felis infections differ;
cross-reactions with SFG rickettsiae as well as with SFG
rickettsiae and R. typhi have been observed, but a lack of
cross-reactions has also been observed [29,34]. In this con-
text, it is important to remind the practising physician that
MIF may be adequate to diagnose the class of infection (e.g.
a spotted fever rickettsiosis) but is likely to be insufﬁcient to
deﬁnitively identify R. felis unless other, more-sophisticated,
serological assays (Western blot and cross-absorption stud-
ies) are performed, or blood or tissue samples can be evalu-
ated by culture or PCR-based methods [34]. However,
although real-time PCR assays are becoming increasingly
used as sensitive and rapid tools to detect and identify rick-
ettsiae in blood and skin biopsy specimens throughout the
world, these facilities are not available everywhere, particu-
larly in developing countries. As for many rickettsioses, the
reference treatment is based on doxycycline [34].
An Common Agent for ‘Fever of Unknown
Origin’ in Subsaharan Africa?
Until recently, almost nothing was known about R. felis in
sub-Saharan Africa. The bacterium had been detected in ﬂeas
from Ethiopia in 2001 [27], in Gabon in 2005 [35], and in
the Ivory Coast in 2009 [20], but no case had been docu-
mented. In July 2010, two studies were published in the same
issue of Emerging Diseases, challenging the importance of
R. felis infection in patients with unexplained fever [36,37]
(Table 1).
In Senegal, our team investigated the origin of unknown
fever in Senegalese patients who had a negative test result
for malaria [36]. We focused on potential Rickettsia spp.
infection as a cause of fever. Sampling took place during
November 2008 to July 2009 in two rural Senegalese villages
in the Sine-Saloum region: Dielmo (1343¢N, 1624¢W) and
Ndiop (1341¢N, 1623¢W). A total of 204 samples from 134
patients were tested by two quantitative real-time PCRs
(qPCR) for all spotted fever group rickettsiae. We identiﬁed
nine samples from eight patients (6%) that were positive by
both genus-speciﬁc qPCR systems; seven from Dielmo and
one from Ndiop. The prevalence of ﬂea-borne spotted fever
in all tested samples was 4.4%. The overall incidence was
1.7% in Dielmo and 0.3% in Ndiop (7/391 vs. 1/313; p 0.06).
Reasons for the signiﬁcantly different prevalence of these
infectious diseases in the two geographically close villages
remained unexplained. A higher attack rate of ﬂea-borne
spotted fever was identiﬁed in children <10 years of age,
with an attack rate of 3.5% in Dielmo during a 9-month per-
iod. Monthly incidence for positive samples was up to 16.7%
in April. Beside fever and unspeciﬁc symptoms (weakness,
headache with sleep disorders, and digestive and respiratory
signs), no rashes and no eschars were found in infected
patients. However, another rickettsial study in an indigenous
African population reported that cutaneous rash might be
imperceptible in patients with pigmented skin. Overall, this
study provided deﬁnitive molecular evidence for R. felis infec-
tion in West Africa in the initial days of infection in febrile
Senegalese patients who did not have malaria [36].
In Kenya, a similar study has been conducted by another
team aiming to determine the aetiologic agents of non-
malaria acute febrile illnesses in the semi-arid North Eastern
Province, Kenya, during inter-epidemic periods of Rift Valley
fever, for 23 months during 2006–2008 [37]. A total of 163
patients with fever were included. Two quantitative real-time
PCR (qPCR) assays were used to screen for rickettisal
nucleic acid in the patients’ serum samples. A R. felis-speciﬁc
qPCR was also used. At the end, nucleic acid preparations of
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serum from 6 (3.7%) of 163 patients were positive for rick-
ettsial DNA as determined by qPCR and were subsequently
conﬁrmed by molecular sequencing to be positive for R. felis.
The six febrile patients’ symptoms included headache, nau-
sea, and muscle, back and joint pain. No patients reported
skin rash, and no information about possible eschars was
available. Most of the cases were diagnosed during August
2007 to June 2008. All patients reported contact with live-
stock animals in a place where all livestock owners in the
region have dogs that assist with livestock herding and secu-
rity. This was the ﬁrst evidence of R. felis infection of humans
in Kenya, and the ﬁrst in eastern sub-Saharan Africa [37].
Unanswered Questions
Much of the ecology of the agent of ﬂea-borne spotted fever
remains unresolved, including R. felis—C. felis interactions.
The role of other arthropods in the life cycle of R. felis and
the epidemiology of human infections also deserves more
investigations. R. felis infection cases have been reported
globally. This may be linked to the worldwide distribution of
the as yet only known ﬂea vectors. However, the occur-
rence is relatively rare when compared with the high fre-
quency of R. felis infections related to ﬂea infestation.
On the other hand, two studies conducted with robust
methods in western and eastern sub-Saharan Africa reported
in 2010 a signiﬁcant incidence of R. felis infection within
patients with fever of unknown origin [36,37]. It has been
speculated in both studies that these patients might have been
exposed to ﬂeas. However, recent studies raised the question
of potential arthropod vectors, different to those that have
been already associated with R. felis. Arthropod cell lines
capable of supporting R. felis growth include those of Toad
tadpole (Xenopus laevis), ticks (Ixodes scapularis) and mosqui-
toes (Aedes albopictus and Anopheles gambiae). Recently, R. felis
has been detected and then isolated in psocid Liposcelis bostry-
chophila (Psocoptera: Liposcelidae), which are common and
cosmopolitan household pest insects often intimately associ-
ated with humans and other vertebrates [38,39].
Conclusion
R. felis is an emergent rickettsial pathogen with a worldwide
distribution. Cases remain poorly characterized and are
apparently under-appreciated, possibly because of the lack of
speciﬁc signs and symptoms, and the low availability of appro-
priate laboratory tests. Ideally, patients in sub-Saharan Africa
with unexplained fever should be tested for R. felis infectionT
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using molecular methods. To date, this technique is, however,
poorly available locally, with the exception of speciﬁc pro-
jects. The current understanding of R. felis biology leaves sev-
eral issues that need to be addressed. More studies are
needed, including the study of other arthropod vectors, but it
can be speculated that R. felis infection might be an important
neglected agent of fever in sub-Saharan Africa.
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